MEDIA MOMENTS | Quest Clinical

Clinical Research Studies

Quest carries out Phase I, II, and III studies for pharmaceutical and research companies operating in the following therapeutic areas:

HIV (cure, research, & treatment)

Hepatitis B (cure & research)

NASH/Fatty Liver

Learn More Or Enroll

Triple Negative Breast Cancer

Solid Tumor Cancers

Media Moments

Click Play for 'Call Dr. Jay' Song

Click Play for 'I feel terrible' flu ad

Screen Shot 2021-05-14 at 7.30.45 AM.png

5/14/21 Video: Hope for Critically Ill Covid-19 Patients Within Reach

03/16/21: Open Letter to the FDA concerning Leronlimab.

revised 4/17/21

read more>

08/27/20: Youth radio interview with Dr. Jay about his work and Covid 19

listen now>

06/03/21: Yellow Ferry Resident Takes on Covid-19

read more>

04/23/20 SF Chronicle: "Two drugs studied in Bay Area could lessen coronavirus deaths, hospitalizations"

3Screen Shot 2020-04-24 at 2.22.53 PM.jp

04/23/20: San Francisco researchers weigh in on coronavirus drugs being studied Kron 4 News

KQED 'PERSPECTIVES'

What AIDS Taught Me

photo by jaywatson.com

Local Article: "Jay Lalezari: Poet’s Soul, Healer’s Heart and Hands"

First clinical trial of Sofosbuvir showing 100% cure rate in Hepatitis C patients

2Screen Shot 2020-05-02 at 9.49.58 PM co

Ibalizumab reduces viral load in patients with MDR HIV

read more >

Dr. Jay's receives High School's Alumni award

2003: This phase III trial lead to approval of Enfuvirtide for Drug-Resistant HIV Infection

Screen Shot 2020-04-24 at 1.35.34 PM.png

Flu Treatment "Relenza"

TV NEWS

Lalezari Family Film:

In memoriam

Cecilia Lalezari

May 30, 1938 - February 26, 2021

03/16/21: Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab

read more>

08/05/20: Cytodyn's Leromlimab receives positive DSMC recommendation in ongoing

Phase 3 study

05/18/20: CytoDyn to submit trial designs of remdesivir vs leronlimab and in combination to battle coronavirus

04/21/20: Development of PRO-140 (Leronlimab) as a treatment for COVID-19

listen now>

04/13/20: CytoDyn sees 'strong results' from leronlimab-treated coronavirus patients

see the video >

Dr Jay Speaks at EASL 2019: On the road to a cure for Hep B

Dr Jay presents BMS oral attachment inhibitor at CROI 2014

The Man Who Smelled Like Rancid Creamed Corn to Usher In a New Scientific Era

2009: Proof of Concept study for the Potent Integrase Inhibitor Dolutegravir

ICAAC 2007: Oral CCR5 inhibitor drug revolutionary for the treatment of some HIV infections

1996 AIDS Conference: COMBINATION THERAPY CAN TREAT AIDS

Screen Shot 2020-04-24 at 1.51.04 PM.png

Flu Treatment

CBS NEWS

04/29/21: OpEd concerning Leronlimab and critically ill Covid-19 patients

read more>

01/06/21: Critically ill Covid patients received leronlimab and had remarkable recoveries measured objectively

read more>

07/02/20: ViiV Healthcare receives FDA approval for Rukobia, a treatment for drug-resistant HIV

11/09/20: CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

read more>

04/21/20: Growing evidence that HIV drug could be game-changer in COVID-19 fight

04/01/20: SF doc sees promise in HIV drug as treatment for COVID19

Your Money or Your Life

Dr. Jay & Bernie Sanders speak on the high cost of Hepitis C treatment

Altered Immune Cells Block HIV

Discover Magazine's #2 story of 2012

04/21/20: Developing Leronlimab as COVID-19 treatment

listen now >

Dr Jay’s research coordinator, Derek, proposes marriage at Burning Man

watch now >

2006: Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows | aidsmap

Screen Shot 2020-04-24 at 1.16.31 PM.png

Herpevac (Herpes vaccine)

ABC NEWS

Screen Shot 2020-04-24 at 1.47.44 PM.png

CMV Retinitis

TV NEWS